Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Kritika Sarmah

What Are Wall Street Analysts' Target Price for Kenvue Stock?

Summit, New Jersey-based Kenvue Inc. (KVUE) is the world's largest pure-play consumer health company. With a market cap of $37.4 billion, the company develops, manufactures, and markets a broad portfolio of over-the-counter (OTC) medicines, skincare, oral care, baby care, and other personal health products that are sold in more than 165 countries.

KVUE stock has declined 11.7% over the past 52 weeks and has grown 14.5% on a YTD basis. In comparison, the S&P 500 Index ($SPX) has returned 16.3% over the past year and risen 8.5% in 2026.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.